Dr. Guqun Shen 沈谷群
Chief Physician, Associate Professor
Department of Gynecology, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of benign and malignant gynecologic tumors, including open, laparoscopic, and hysteroscopic surgery.
Dr. Shen is a Chief Physician and Associate Professor at the Affiliated Cancer Hospital of Xinjiang Medical University. Dr. Shen specializes in open, laparoscopic, and hysteroscopic surgeries and the treatment of gynecologic tumors.
Name order: in Chinese the family name comes first (Shen Guqun). Papers usually list the name as Guqun Shen or Shen G.
Selected publications
15 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Bioenerg Biomembr, 2024 (senior author): N(6)-methyladenosine (m(6)A) reader HNRNPA2B1 accelerates the cervical cancer cells aerobic glycolysis. PubMed 39425888
- Front Oncol, 2024 (senior author): The expression of lnc-CCDC170-4:1, ESR1, lncRNA SRA, and CYP19A1 in cervical squamous cell carcinoma and their relationship with the clinical characteristics. PubMed 39206151
- Clin Transl Oncol, 2024 (senior author): NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway. PubMed 37322227
- J Cytol, 2023 (senior author): Screening of Endometrial Cancer Related to Lynch Syndrome in China by Suction Curettage-Based Cytology and Histology: A Retrospective Study. PubMed 37388402
- World J Surg Oncol, 2023 (first author): New insights on the interaction between m(6)A modification and non-coding RNA in cervical squamous cell carcinoma. PubMed 36710350
- Hum Exp Toxicol, 2022 (senior author): Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway. PubMed 35722665
- Hum Exp Toxicol, 2021 (senior author): Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway. PubMed 34791915
- Int J Clin Exp Med, 2014 (first author): Viral DNA load of high-risk human papilloma virus is closely associated with the grade of cervical lesions. PubMed 25664114
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion